The Ex Vivo IFN-γ Enzyme-Linked Immunospot (ELISpot) Assay

Martha Sedegah1

  • 1Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA. martha.sedegah@med.navy.mil.

Insights

The Enzyme-linked immunospot (ELISPOT) assay quantifies single cell interferon-gamma (IFN-γ) release, crucial for evaluating cellular immune responses. This method is vital for immunology research, particularly in vaccine development studies.

Area of Science:

  • Immunology
  • Cellular Biology
  • Vaccine Research

Background:

  • The Enzyme-linked immunospot (ELISPOT) assay is a key technique for measuring immune responses at the single-cell level.
  • It quantifies cytokine release, such as interferon-gamma (IFN-γ), from antigen-specific T-cells.

Purpose of the Study:

  • To highlight the utility of the ELISPOT assay in quantifying single-cell cytokine release.
  • To emphasize its application in assessing cellular immune responses and its importance in vaccine research.

Main Methods:

  • Peripheral blood mononuclear cells (PBMC) are stimulated in vitro with various antigens.
  • Stimulation can be short-term (20-36 hours) or long-term (up to 7 days).
  • The assay quantifies specific cytokine production, including IFN-γ, IL-2, and IL-5.

Main Results:

  • ELISPOT effectively quantifies single-cell cytokine secretion in response to diverse stimuli.
  • The assay allows for the assessment of both short-term and long-term cellular immune responses.

Conclusions:

  • The ELISPOT assay is an invaluable tool for quantifying cellular immune responses, especially IFN-γ release.
  • Its versatility and application in vaccine research make it a significant technique in immunology.